Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view.
about
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosminMicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemiaPrognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaIndividual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemiaFlt3 mutations and leukaemia.The role of allogeneic transplantation in high-risk acute myelogenous leukemia.Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.MicroRNAs in the ontogeny of leukemias and lymphomas.miRNAs as molecular biomarkers of cancer.Epigenetically regulated microRNAs and their prospect in cancer diagnosis.The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation.Hematopoietic stem cell transplantation for hematological malignancies in Europe.Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationEarly related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
P2860
Q24652323-86D46814-2ED0-4E76-BF17-F0028FBF470BQ24655915-B47AAE6F-9C1A-4574-986E-5939BB4618CCQ28186429-F367F427-73A5-4941-B8EA-C0509BE1ED9AQ33881750-0A7A2115-975B-41DE-8302-1FE2D5425FD8Q35043364-BE14B2C8-7B52-4952-A35B-0615DAC35A2DQ35192266-09FA4FBB-5774-4516-B68F-46942DF88539Q35903540-B5B9C4B5-252F-4013-BA2F-72171B114374Q36199509-5AA13D5E-52E6-4540-9029-FB3802F3E6F1Q37061964-C09F0DAA-7BD7-483C-8AF8-B41656F62055Q37374567-767D0F81-F632-40FE-B548-9C3997D99A89Q37750843-28E6A9CA-2B3C-4C0C-A7F8-9E298E4BAE4DQ38219046-8AE7DB60-4B35-49CF-AD54-F10236A6CF9DQ44043143-9A45DE85-3F18-41D8-A5CD-FF6539161B6CQ44630730-9DA87B27-C05E-4CAF-9574-11332117901FQ47908471-8FF9B39C-B7D7-4913-A891-58FFFFED4182Q53353482-958B9194-C337-4545-9499-415AA2AF61D7Q57252636-82F0EF37-FF0F-4AEA-9325-C079333F82ABQ57515087-C38D88E2-C74F-428E-9B47-988130944D23
P2860
Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Current controversies: which p ...... ion?--an adult treater's view.
@ast
Current controversies: which p ...... ion?--an adult treater's view.
@en
Current controversies: which p ...... ion?--an adult treater's view.
@nl
type
label
Current controversies: which p ...... ion?--an adult treater's view.
@ast
Current controversies: which p ...... ion?--an adult treater's view.
@en
Current controversies: which p ...... ion?--an adult treater's view.
@nl
prefLabel
Current controversies: which p ...... ion?--an adult treater's view.
@ast
Current controversies: which p ...... ion?--an adult treater's view.
@en
Current controversies: which p ...... ion?--an adult treater's view.
@nl
P2860
P1476
Current controversies: which p ...... ion?--an adult treater's view.
@en
P2093
Alan K Burnett
P2860
P304
P356
10.1046/J.1365-2141.2002.03698.X
P407
P577
2002-08-01T00:00:00Z